Underpinning our five other Research Themes is the Digital Cancer Centre. Our ambition is that the Digital Cancer Centre will aid in the seamless integration of digital technologies and targeted clinical trials. It will be driven by patient’s data and novel, precision treatments and support activities across Integrative Pathology, Radiotherapy BioAdaption, Cancer Biomarkers, Cancer Early Detection and Experimental Cancer Medicine.
An exciting ecosystem
The Digital Cancer Centre brings together all digital assets within The Christie, the MCRC, the University of Manchester, and the Pankhurst Institute into one rich ecosystem. All data will connect to patient medical records at The Christie, and by bringing digital assets under one umbrella, it becomes possible to ask questions about individual patients at an extraordinarily granular level.
As we finalise our strategy for the integration of digital technologies into our research themes, we’ll share more about how the Digital Cancer Centre will uplift specific research projects and programmes.
Cancer biomarkers are core to our vision of delivering precision medicine for all.
Cancer Early Detection
To beat cancer sooner, we need to detect it sooner. Find out about our focus on early detection science.
Experimental Cancer Medicine
To improve patient lives, we need new therapies and treatments and early phase clinical trials to continue to be developed.
Acquisition of patient samples is key to translational research and we have developed an extensive biobanking infrastructure to allow collection at all points of the treatment pathway.
Radiotherapy plays a vital role in the treatment of cancer and nearly 50% of people receive some form of radiotherapy at some point during cancer treatment.
Discover more about the five research themes and underpinning Digital Cancer Centre prioritised at the CRUK Manchester Centre
Christabel Pankhurst Institute For health technology research and innovation
The Institute is a £25m initiative to promote needs-led health technology research and innovation, providing end-to-end support for translation into practice, and acting as an external flagship for the University’s rapidly expanding health technology portfolio.